Literature DB >> 28270442

A four-compartment compartmental model to assess net whole body protein breakdown using a pulse of phenylalanine and tyrosine stable isotopes in humans.

Alvise Mason1,2, Mariëlle P K J Engelen1, Ivan Ivanov3, Gianna M Toffolo2, Nicolaas E P Deutz4.   

Abstract

The stable isotopes of phenylalanine (Phe) and tyrosine (Tyr) are often used to study whole body protein metabolism in humans. Noncompartmental approaches give limited physiological insight in the compartmental characteristics. We therefore developed a compartmental mathematical model of Phe/Tyr metabolism to describe protein fluxes by using stable tracer dynamic data in plasma following intravenous bolus of l-[ring-13C6]Phe and l-[ring-2H4]Tyr in healthy subjects. The model consists of four compartments describing Phe/Tyr kinetics. Because the model is a priori nonidentifiable, it is quantified in terms of two uniquely identifiable submodels representing two limit case scenarios, based on known physiology. The two submodels, identified by using the software SAAM II, fit well the experimental data of all individuals and provide an unbiased overview of the metabolic pathway in terms of intervals of validity of the non-uniquely identifiable variables. The model provides estimates of the flux from Phe to Tyr [4.1 ± 1.0 µmol·kg fat-free mass (FFM)-1·h-1 (mean ± SE)] and intervals of validity of the flux and pool estimates. Our preferred submodel yielded protein breakdown flux (50.5 ± 5.2 µmol·kg FFM-1·h-1), net protein breakdown (4.1 ± 1.0 µmol·kg FFM-1·h-1), Tyr from Phe hydroxylation (~12%), hydroxylated Phe (~8%), and flux ratio of Tyr to Phe arising from protein catabolism (0.68), consistent with available literature. The other submodel suggest that the assumptions made by noncompartmental analysis are consistently underestimated. Our accurate and detailed model for estimating Phe/Tyr metabolic pathways in humans might be essential to applications in a variety of scenarios describing whole body protein synthesis and breakdown in health and disease.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  compartmental model; parameter estimation; phenylalanine; stable isotopes; tracer kinetics; tyrosine

Mesh:

Substances:

Year:  2017        PMID: 28270442      PMCID: PMC6109702          DOI: 10.1152/ajpendo.00362.2016

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  19 in total

1.  DAISY: a new software tool to test global identifiability of biological and physiological systems.

Authors:  Giuseppina Bellu; Maria Pia Saccomani; Stefania Audoly; Leontina D'Angiò
Journal:  Comput Methods Programs Biomed       Date:  2007-08-20       Impact factor: 5.428

2.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

Authors:  P H Barrett; B M Bell; C Cobelli; H Golde; A Schumitzky; P Vicini; D M Foster
Journal:  Metabolism       Date:  1998-04       Impact factor: 8.694

3.  Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model.

Authors:  G N Thompson; P J Pacy; H Merritt; G C Ford; M A Read; K N Cheng; D Halliday
Journal:  Am J Physiol       Date:  1989-05

4.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis.

Authors:  C Cobelli; J J DiStefano
Journal:  Am J Physiol       Date:  1980-07

5.  Studies of amino acid and protein metabolism in normal man with L-[U-14C]tyrosine.

Authors:  W P James; P J Garlick; P M Sender; J C Waterlow
Journal:  Clin Sci Mol Med       Date:  1976-06

Review 6.  An overview of phenylalanine and tyrosine kinetics in humans.

Authors:  Dwight E Matthews
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

7.  Compartmental model of leucine kinetics in humans.

Authors:  C Cobelli; M P Saccomani; P Tessari; G Biolo; L Luzi; D E Matthews
Journal:  Am J Physiol       Date:  1991-10

8.  The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.

Authors:  H C Curtius; J A Völlmin; K Baerlocher
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

9.  Phenylalanine and tyrosine kinetics in relation to altered protein and phenylalanine and tyrosine intakes in healthy young men.

Authors:  J Cortiella; J S Marchini; S Branch; T E Chapman; V R Young
Journal:  Am J Clin Nutr       Date:  1992-09       Impact factor: 7.045

10.  A compartmental model of 3-methylhistidine metabolism in humans.

Authors:  J A Rathmacher; P J Flakoll; S L Nissen
Journal:  Am J Physiol       Date:  1995-07
View more
  9 in total

1.  Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD.

Authors:  Mariëlle P K J Engelen; Renate Jonker; John J Thaden; Gabriella A M Ten Have; Moon Sun Jeon; Srinivasan Dasarathy; Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2020-01-29       Impact factor: 7.324

2.  A novel triple-tracer approach to assess postprandial protein turnover.

Authors:  Antoinette Moran; Gianna Toffolo; Michele Schiavon; Adrian Vella; Katherine Klaus; Claudio Cobelli; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-05       Impact factor: 4.310

Review 3.  Tracing metabolic flux in vivo: basic model structures of tracer methodology.

Authors:  Il-Young Kim; Sanghee Park; Yeongmin Kim; Hee-Joo Kim; Robert R Wolfe
Journal:  Exp Mol Med       Date:  2022-09-08       Impact factor: 12.153

4.  Metabolic phenotyping using kinetic measurements in young and older healthy adults.

Authors:  Nicolaas E P Deutz; John J Thaden; Gabriella A M Ten Have; Dillon K Walker; Mariëlle P K J Engelen
Journal:  Metabolism       Date:  2017-10-03       Impact factor: 8.694

5.  Comprehensive metabolic amino acid flux analysis in critically ill patients.

Authors:  Nicolaas E P Deutz; Pierre Singer; Raven A Wierzchowska-McNew; Marina V Viana; Itai A Ben-David; Olivier Pantet; John J Thaden; Gabriella A M Ten Have; Mariëlle P K J Engelen; Mette M Berger
Journal:  Clin Nutr       Date:  2021-03-18       Impact factor: 7.324

6.  A low postabsorptive whole body protein balance is associated with markers of poor daily physical functioning in Chronic Obstructive Pulmonary Disease.

Authors:  Clayton L Cruthirds; Nicolaas E P Deutz; Rajesh Harrykissoon; Anthony J Zachria; Mariëlle P K J Engelen
Journal:  Clin Nutr       Date:  2022-03-03       Impact factor: 7.324

7.  Activated whole-body arginine pathway in high-active mice.

Authors:  Jorge Z Granados; Gabriella A M Ten Have; Ayland C Letsinger; John J Thaden; Marielle P K J Engelen; J Timothy Lightfoot; Nicolaas E P Deutz
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

8.  Nitrogen recycling buffers against ammonia toxicity from skeletal muscle breakdown in hibernating arctic ground squirrels.

Authors:  Sarah A Rice; Gabriella A M Ten Have; Julie A Reisz; Sarah Gehrke; Davide Stefanoni; Carla Frare; Zeinab Barati; Robert H Coker; Angelo D'Alessandro; Nicolaas E P Deutz; Kelly L Drew
Journal:  Nat Metab       Date:  2020-12-07

9.  Disturbances in branched-chain amino acid profile and poor daily functioning in mildly depressed chronic obstructive pulmonary disease patients.

Authors:  Marisa R Pinson; Nicolaas E P Deutz; Rajesh Harrykissoon; Anthony J Zachria; Mariëlle P K J Engelen
Journal:  BMC Pulm Med       Date:  2021-11-07       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.